Cargando…

Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer

Ovarian cancer has a high recurrence rate after platinum‐based chemotherapy. To improve the treatment of ovarian cancer and identify ovarian cancer‐specific antibodies, we immunized mice with the human ovarian carcinoma cell line, SKOV‐3, and generated hybridoma clones. Several rounds of screening y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Feng‐Yi, Chen, Wan‐Yu, Lin, Ming‐Chieh, Hwang, Yu‐Chyi, Kuo, Kuan‐Ting, Wu, Han‐Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Basic and Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541015/ https://www.ncbi.nlm.nih.gov/pubmed/32648337 http://dx.doi.org/10.1111/cas.14566

Ejemplares similares

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
por: Caracciolo, Daniele, et al.
Publicado: (2021)

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
por: Chen, Heyu, et al.
Publicado: (2020)

Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments
por: Moreno-Vicente, Julia, et al.
Publicado: (2022)

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
por: Hwang, Yu-Chyi, et al.
Publicado: (2022)

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
por: Higgs, Brandon W, et al.
Publicado: (2014)

Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas
por: Kishima, H, et al.
Publicado: (1999)

Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease
por: Bos, Amelie, et al.
Publicado: (2022)

Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
por: Yan, Wan-Lun, et al.
Publicado: (2021)

Detection of Signal Regulatory Protein α in Saimiri sciureus (Squirrel Monkey) by Anti-Human Monoclonal Antibody
por: de Souza, Hugo Amorim dos Santos, et al.
Publicado: (2017)

Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
por: Chen, Jiaying, et al.
Publicado: (2023)

Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates
por: Swanson, Michael D., et al.
Publicado: (2022)

Therapeutic strategies targeting folate receptor α for ovarian cancer
por: Mai, Jia, et al.
Publicado: (2023)

Epitope Mapping for Monoclonal Antibody Reveals the Activation Mechanism for αVβ3 Integrin
por: Kamata, Tetsuji, et al.
Publicado: (2013)

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
por: van Helden, Mary J, et al.
Publicado: (2023)

The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies
por: Gurjar, Shalom A., et al.
Publicado: (2019)

Advances in the Isolation of Specific Monoclonal Rabbit Antibodies
por: Zhang, Zaibao, et al.
Publicado: (2017)

38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

Generation of Antibody-Producing Hybridomas Following One Single Immunization with a Targeted DNA Vaccine
por: Øynebråten, I, et al.
Publicado: (2012)

Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells
por: König, Martin, et al.
Publicado: (2016)

Characterization of Monoclonal Antibodies Recognizing Citrulline-Modified Residues
por: Chen, Yaqiong, et al.
Publicado: (2022)

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
por: Ao, Xiang, et al.
Publicado: (2019)

Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights
por: Xu, Shihan, et al.
Publicado: (2021)

Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
por: Deligne, Claire, et al.
Publicado: (2017)

The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass
por: Deveuve, Quentin, et al.
Publicado: (2020)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
por: Quadri, Iman, et al.
Publicado: (2023)

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
por: Kalinovsky, Daniel V, et al.
Publicado: (2022)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Use of an Immobilized Monoclonal Antibody to Examine Integrin α5β1 Signaling Independent of Cell Spreading
por: Bao, Wenjie, et al.
Publicado: (2002)

Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies
por: Wall, Jonathan S., et al.
Publicado: (2011)

Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
por: Jaworski, Juan Pablo, et al.
Publicado: (2017)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
por: Alfaleh, Mohamed A., et al.
Publicado: (2020)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
por: Martinez-Navio, José M., et al.
Publicado: (2020)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability
por: Chen, Lei, et al.
Publicado: (2023)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pnq01t6qio2obna0an194fhs6p